Cargando…
Unlocking the power of precision medicine for pediatric low-grade gliomas: molecular characterization for targeted therapies with enhanced safety and efficacy
In the past decade significant advancements have been made in the discovery of targetable lesions in pediatric low-grade gliomas (pLGGs). These tumors account for 30-50% of all pediatric brain tumors with generally a favorable prognosis. The latest 2021 WHO classification of pLGGs places a strong em...
Autores principales: | Cipri, Selene, Del Baldo, Giada, Fabozzi, Francesco, Boccuto, Luigi, Carai, Andrea, Mastronuzzi, Angela |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10311254/ https://www.ncbi.nlm.nih.gov/pubmed/37397394 http://dx.doi.org/10.3389/fonc.2023.1204829 |
Ejemplares similares
-
How Genetics and Genomics Advances Are Rewriting Pediatric Cancer Research and Clinical Care
por: Cipri, Selene, et al.
Publicado: (2022) -
Cancer Predisposition Syndromes Associated With Pediatric High-Grade Gliomas
por: Ceglie, Giulia, et al.
Publicado: (2020) -
CAR-T Therapy for Pediatric High-Grade Gliomas: Peculiarities, Current Investigations and Future Strategies
por: Antonucci, Laura, et al.
Publicado: (2022) -
DICER1 Syndrome and Cancer Predisposition: From a Rare Pediatric Tumor to Lifetime Risk
por: Caroleo, Anna Maria, et al.
Publicado: (2021) -
Pediatric Diffuse Midline Gliomas: An Unfinished Puzzle
por: Di Ruscio, Valentina, et al.
Publicado: (2022)